Allogene Therapeutics(ALLO)
搜索文档
Allogene Therapeutics(ALLO) - 2021 Q3 - Earnings Call Transcript
2021-11-05 11:43
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2021 Earnings Conference Call November 4, 2021 5:00 PM ET Company Participants Christine Cassiano – Chief Communications Officer David Chang – President and Chief Executive Officer Rafael Amado – Executive Vice President of Research and Development and Chief Medical Officer Eric Schmidt – Chief Financial Officer Conference Call Participants Tyler Van Buren – Cowen Michael Schmidt – Guggenheim John Newman – Canaccord Luca Issi – RBC Capital Salveen Richter – Goldm ...
Allogene Therapeutics(ALLO) - 2021 Q2 - Earnings Call Transcript
2021-08-05 10:36
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2021 Earnings Conference Call August 4, 2021 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and CEO Rafael Amado - EVP, Research and Development and CMO Eric Schmidt - CFO Conference Call Participants Marc Frahm - Cowen & Company Luca Issi - RBC Salveen Richter - Goldman Sachs Jason Gerberry - Bank of America John Newman - Canaccord Mark Breidenbach - Oppenheimer Reni Benjamin - JMP Securities Raju Prasad ...
Allogene Therapeutics(ALLO) - 2021 Q1 - Earnings Call Transcript
2021-05-06 10:33
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2021 Earnings Conference Call May 5, 2021 5:00 PM ET Company Participants Christine Cassiano - CCO David Chang - President and CEO Rafael Amado - EVP-Research and Development and CMO Eric Schmidt - CFO Conference Call Participants Salveen Richter - Goldman Sachs Marc Frahm - Cowen & Company Kelly Shi - Jefferies Michael Schmidt - Guggenheim John Newman - Canaccord Cory Kasimov - J.P. Morgan Luca Issi - RBC Capital Mark Breidenbach - Oppenheimer Ben Burnett - Stif ...